Ab Science Stock Quote 0Q77 - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
UK
LSE
Ab Science Sa (0Q77) Quote

Ab Science Sa (0Q77)

3.835

0.00

(0.00%)

Closed November 05 11:30AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

3.835

Bid

3.74

Ask

3.93

Volume

2

0.00 Day's Range 0.00

3.835 52 Week Range 3.835

Market Cap

Previous Close

3.835

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

597

Shares Outstanding

46,602,000

Dividend Yield

-

PE Ratio

-3.77

Earnings Per Share (EPS)

-0.26

Revenue

970k

Net Profit

-11.99M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ab-science.com

Headquarters

Paris, Paris, Fra

Founded

-

Ab Science Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Q77. The last closing price for Ab Science was 3.84 €. Over the last year, Ab Science shares have traded in a share price range of 3.835 € to 3.835 €.

Ab Science currently has 46,602,000 shares outstanding. The market capitalization of Ab Science is 178.72 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.77.

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON...

AB Science annonce un léger décalage de la publication de son rapport financier du premier semestre 2024

AB Science annonce un léger décalage de la publication de son rapport financier du premier semestre 2024 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT...

AB Science announces a slight delay in the publication of its 2024 half-year financial report

AB Science announces a slight delay in the publication of its 2024 half-year financial report PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2024 HALF-YEAR FINANCIAL...

AB Science annonce une augmentation de capital de 5,0 millions d’euros

AB Science annonce une augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE REALISATION AVEC SUCCES D’UNE AUGMENTATION DE CAPITAL PAR PLACEMENT PRIVE POUR UN MONTANT DE 5 MILLIONS...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	3.835	3.835	3.835	1212	3.835	DE
4	0	0	3.835	3.835	3.835	1331	3.835	DE
12	0	0	3.835	3.835	3.835	597	3.835	DE
26	0	0	3.835	3.835	3.835	867	3.835	DE
52	0	0	3.835	3.835	3.835	2442	3.835	DE
156	0	0	3.835	3.835	3.835	4556	3.835	DE
260	0	0	3.835	3.835	3.835	4564	3.835	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AFRNAferian Plc	6.00p (84.62%)	3M
BBBBigblu Broadband Plc	37.50p (47.06%)	922.29k
SLFRSlf Realisation Fund Limited	1.50p (27.66%)	1.67M
JANJangada Mines Plc	1.30p (18.18%)	704.96k
GSTGstechnologies Ltd	1.25p (17.92%)	74.3M
ACPArmadale Capital Plc	0.06p (-23.57%)	1.73M
SYNSynergia Energy Ltd	0.0525p (-22.22%)	459.07M
GMPGabelli Merger Plus+ Trust Plc	$ 7.00 (-22.22%)	4.64k
UOGUnited Oil & Gas Plc	0.26p (-18.75%)	144.17M
KODKodal Minerals Plc	0.325p (-16.67%)	641.19M
TRPTower Resources Plc	0.031p (3.33%)	891.45M
NTVONativo Resources Plc	0.0025p (-7.41%)	767.68M
KODKodal Minerals Plc	0.325p (-16.67%)	641.19M
SYNSynergia Energy Ltd	0.0525p (-22.22%)	459.07M
CLONClontarf Energy Plc	0.039p (-2.50%)	392.08M

aBeezlee

aBeezlee 52 seconds ago

Ouch. Sharp haircut.

Poo28

Poo28 56 seconds ago

TY for important point and focus on presentation.

The AI & Technology Conference had 8 presenters, each of whom was invited to participate by OTC Markets . No BS about Registration Fees , always required from Davos to college.

Fact: 7 presenters were from Company QX or

zooey

zooey 1 minute ago

Try this link:

https://apps.ilsos.gov/businessentitysearch/businessentitysearch

Bubae

Bubae 1 minute ago

Automated trading friendo. Caution, pros at work. Still holding your shares? 🤣 Oh, that's right, another 2 billion shares added wouldn't bother you. 😆

SorcererDiviner18
Re: None
Saturday, February 10, 2024 12:28:04 PM
Post# 11323 of 14660
ht

jimr1717

jimr1717 1 minute ago

Shorting scams like this is a no brainer. It’s best to short it the day after the next reverse split.

Market Makers Exist

Market Makers Exist 2 minutes ago

Dilution might be happening, but not concerned. That means cheaper shares. SPZI with 5.5B OS went copper. ILST will be fine even with a little dilution.

ramfan60

ramfan60 2 minutes ago

I disagree but we shall see.

BDEZ

BDEZ 2 minutes ago

Good to know, thanks for sharing.

nsomniyak

nsomniyak 2 minutes ago

I agree that IONQ is certainly worth not just watching, but buying.

That said, with a $3B market cap it really does not belong on this board.

Beerworld

Beerworld 2 minutes ago

Well that would be scary but I have a different scenario. 😕

linkvest

linkvest 2 minutes ago

Thanks for the lotto of 5s this morning.. Like I really need more lol.....

Kool Aid Man

Kool Aid Man 2 minutes ago

Wrong--I/we want scammers/crooks to stop getting rich by lying to investors. The SEC does the same thing. In case you forgot The U.S. Securities and Exchange Commission is an independent agency of the United States federal government, created in the aftermath of the Wall Street Crash of 1929. Its p

bobby1151

bobby1151 3 minutes ago

How many times have we heard that garbage?? Like CVS, KT Tape, Synergy!

janice shell

janice shell 3 minutes ago

Doesn't an inner temperature of 203 degrees seem a bit high? Or would it get that hot if you were braising it?

Jimmy Joe

Jimmy Joe 3 minutes ago

You sold, or did you~? Just can't move on can you Bro~?

My guess ..............you lost a ton of money in this play.

Or you never were a shareholder.

$DBMM baby~!

surfkast

surfkast 3 minutes ago

Would this be toxic funding?
JP3E is relying on 'charitable donations' and 'share purchases' by it to fund operations. This was revealed for the first time ever in May thanks to Park's audit of 2022 - 2023. The last page of Q2 shows these donations are ongoing. The source is a sketchy 501(c)(

biotech_researcher

biotech_researcher 3 minutes ago

Reverse Split is all but certain...

Hoonigan

Hoonigan 3 minutes ago

Where's Borax and Shonney going?
https://www.gifservice.fr/img/gif-vignette-small/ea74104755159b290e631e223ed60ac5/375353-multi-media-cartoons-tv-movies-wacky-races-motors-race-video-gif-06.gif

RobotDroid

RobotDroid 3 minutes ago

Only the fools here keep saying weeks. Weeks became 4 years plus.

nsomniyak

nsomniyak 4 minutes ago

I am waiting to see NIXX prove its business model before I jump in. So far all they have done is promise to spin out some assets into a shell (AESO) that I happen to have a legacy position in. Although this may in fact provide some real value in the AESO position I pretty much considered at least

crazy horse 0

crazy horse 0 4 minutes ago

Russia Will Adequately Respond to Aggression of NATO, Member States - Lavrov

excerpt:
Notable quote-"And no one will be safe either beyond the Atlantic Ocean or the English Channel," Lavrov said.
56 minutes ago (Updated: 32 minutes ago)
Launch of the Iskander-M ba

Ga-Pro

Ga-Pro 4 minutes ago

Well boys looks like a write off. They have no money they are going to dilute the hell out of this

titan11

titan11 4 minutes ago

Which numbers are you talking about? My numbers are excellent! Bought 4's and sold 80 % between 9 & 11.

Canadian Silver Hunter

Leonteq Securities

BNP Paribas Issuance

Dekel Agri-Vision

Celebrus Technologies

Delayed Upgrade Clock